Hultquist, PLLC
Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same
The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
PharmAbcine Inc.
C C A C A C C C G G C A A C C C C C A A
C07K C07K A61P C07K A61P C07K C07K C07K G01N G01N C07K A61P A61P C07K C07K C07K C07K C07K A61P A61P
additional additional inventional additional inventional inventional additional additional additional inventional additional inventional inventional inventional additional additional inventional additional inventional inventional
Ju Ryung Jin San Jae Bong Sung Woo Young Ae Jin Hee Eun Jin Jin Sook Bo Young Sang Hoon Do Yun Sang Ryeol Seon Hwan Kyung Hee Sang Soon Jin Sang Mi Ju Weon Sup Jong Geun Seon Young Joong Kyu Hyuk Joon In Sook Nam Ye Yeun Ju
Nam Yoo Yoon Kim Lee Choi Lee Lee Jeong Lee Kim Shim Oh Nahm Byun Yoo Park Lee Jeong Lee Kim Lee Park Kim Kim